Abstract
During the early months of the SARS-CoV-2 pandemic, notable uncertainty emerged regarding the role of children in transmission dynamics 1. With time, it became more clear that children were susceptible to infection with SARS-CoV-2, but that the vast majority of children experienced mild symptoms with lower incidence of severe disease 2. This pattern remained consistent despite the later emergence of SARS-CoV-2 variants, including Delta and Omicron, even among children <5 ineligible for vaccination3. The relative lack of severe disease in the pediatric population raised questions regarding viral kinetics and infectivity in children versus adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by funding from NIH P30GM118228-04.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Vermont's Institutional Review Board and the Children's Wisconsin Institutional Review Board waived ethical approval of this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest Disclosures: The authors have no conflicts to disclose.
Funding/Support: This study was supported by NIH grant P30GM118228-04 (to E.A.B., J.W.C. and B.L.)
Role of Funder: The NIH had no role in the design and conduct of the study.
Madaline Schmidt collected data, carried out the initial analyses, drafted the initial manuscript and critically reviewed and revised the manuscript.
Hannah Despres collected data and critically reviewed and revised the manuscript.
David Shirley carried out data analysis and presentation, and critically reviewed and revised the manuscript.
Michael Bose and Kate McCaul coordinated sample collection and acquisition, and critically reviewed and revised the manuscript.
Dr Jessica Crothers conceptualized and designed the study and critically reviewed and revised the manuscript.
Dr Kelly Henrickson conceptualized and designed the study, coordinated sample collection and IRB permission (MCW), and critically reviewed and revised the manuscript.
Dr Benjamin Lee conceptualized and designed the study, coordinated sample acquisition and IRB permission (UVM), and critically reviewed and revised the manuscript.
Dr Emily Bruce conceptualized and designed the study, coordinated and supervised data collection, drafted the initial manuscript and critically reviewed and revised the manuscript.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Data Availability
Code is available at https://github.com/emilybrucelab. All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- SARS-CoV-2
- (severe acute respiratory syndrome coronavirus 2)
- COVID-19
- (coronavirus disease 2019)
- CT
- (cycle threshold)
- RT-qPCR
- (reverse transcription-quantitative polymerase chain reaction)
- RNA
- (ribonucleic acid)
- TMPRSS2
- (transmembrane protease, serine 2)
- FFU
- (focus forming unit)
